Eloralintide, LY3841136, 2883634-40-8
83 Inquiries
2883634-40-8
Reagent Grade
98%
shanghai
cellmano
1g
2029-12-31
Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.
Basic Info-
Product Name:
Eloralintide
Other Name:Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136
CAS No.:2883634-40-8
Molecular Weight:0
EC Number:262-076-3
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) agonist (peptide, long-acting)
Status:Investigational — Phase 1/2 (T2DM and obesity)
Mechanism:Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.
Activity note:Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.
Source:MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.
References-
PubChem:Disclaimer:
Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide
-
Location:
Room C608, Chiyuan venture park
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
10 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
Cellmano Biotech Limited focus on researching and developing solid phase peptide synthesis methodology since 2011. Cellmano has 10 years experience in researching, developing and manufacturing peptides by solid peptide phase synthesis.
Cellmano not only provides cosmeceuticals peptide & generic peptides to the customers, but also offer peptide CMO service and custom peptides synthesis service depend on the requirement from the customers over the world. Cellmano has state-of-the-art labs armed with excellent instrument for synthesis, purify and analysis .Cellmao control the quality by checking the materials, supervising produce process and finally QC. Cellmano keep all the synthesis records , purify methods and analysis result for every batch peptide product with staff and time invovled in the archives. Synthesizing by classical solid phase mothed invented by Prof.Bruce Merrified and purifying by HPLC instrument, Cellmano supply the customers excellent peptide products with reasonable price ,while maintain high quality, to help the customers to cut down their cost and shorten the time . Cellmano is trying her best to complement the inventory for more than 2000 popular peptide products, to make sure the customers can get what they need in one week from Cellmano’s inventory. Also to saitisfy diverse request from different customers for different projects, Cellmano provide custom synthesis for peptides from mgs to kgs with the purity from crude to 98% .
-
-
Inquiry History83 Inquiries
Country Product Purchase Quantity Date Posted
Germany
Eloralintide, Lyophilised (Freeze-Dried) Peptides – High Purity / Low Endotoxin (LPS Removed)
100 Oct 26, 2026
United States
Eloralintide (LY-3841136)
1 Oct 24, 2026
Netherlands
Eloralintide
10 MG Oct 22, 2026
France
eloralintide
1 MT Oct 21, 2026
South Korea
Eloralintide
1 G Oct 21, 2026
United States
Eloralintide
10 PCS Oct 21, 2026
United Kingdom
Eloralintide
100 PCS Oct 20, 2026
United States
Eloralintide
20 MG Oct 19, 2026
United States
Eloralintide
1 MT Oct 16, 2026
United States
Eloralintide
10 MT Oct 10, 2026
Germany
Eloralintide
1 PCS Oct 10, 2026
United States
eloralintide
10 MG Oct 6, 2026
United States
Eloralintide
10 MG Oct 5, 2026
United Kingdom
Eloralintide vials
5 PCS Oct 4, 2026
Australia
ELORALINTIDE
10 PCS Oct 2, 2026
Brazil
Eloralintide
5 MT Oct 2, 2026
Australia
Eoralintide
10 PCS Oct 1, 2026
United Kingdom
Eloralitide
2 G Sep 27, 2026
United Kingdom
Eloralintide
30 MG Sep 22, 2026
United States
Eloralintids
10 MG Sep 18, 2026 Post an enquiry for this product
- Hot Searches
- reta weight loss where to buy
- where do they sell kerosene
- soda ash dense price
- copper chloride msds
- dayquil vs nyquil ingredients
- cheapest retatrutide
- mono propylene glycol for sale
- retatrutide buy online usa
- dimethylmercury
- phosphorus pure
- dibasic calcium phosphate
- price of anhydrous ammonia today
More from this Seller
-
-
-
GHK peptide, Prezatide, Liver Cell Growth Factor 98% white powder L-1104 cellmano
Chemical Grade / 98%
$10-12/G FOB
-
-
-
-
Lysipressin, 50-57-7
Reagent Grade / 98%
$180-200/G FOB
-
-
-
-
N-Acetyl Selank Amidate, 2212313-10-6
Reagent Grade / 98%
$120-150/G FOB
-
-
-
-
Acetyl Decapeptide-3, Rejuline, 935288-50-9
Chemical Grade / 95%
$70-80/G FOB
-
-
-
-
Argireline, Acetyl Hexapeptide-3/Acetyl Hexapeptide-8, 616204-22-9
Chemical Grade / 98%
$25-30/G FOB
-
-
-
-
Acetyl Tetrapeptide-5, Eyeseryl, 820959-17-9
Reagent Grade / 98%
$40-50/G FOB
-